253 related articles for article (PubMed ID: 15901849)
1. Mutations linked to autosomal dominant nocturnal frontal lobe epilepsy affect allosteric Ca2+ activation of the alpha 4 beta 2 nicotinic acetylcholine receptor.
Rodrigues-Pinguet NO; Pinguet TJ; Figl A; Lester HA; Cohen BN
Mol Pharmacol; 2005 Aug; 68(2):487-501. PubMed ID: 15901849
[TBL] [Abstract][Full Text] [Related]
2. Five ADNFLE mutations reduce the Ca2+ dependence of the mammalian alpha4beta2 acetylcholine response.
Rodrigues-Pinguet N; Jia L; Li M; Figl A; Klaassen A; Truong A; Lester HA; Cohen BN
J Physiol; 2003 Jul; 550(Pt 1):11-26. PubMed ID: 12754307
[TBL] [Abstract][Full Text] [Related]
3. Properties of mutated murine alpha4beta2 nicotinic receptors linked to partial epilepsy.
Lipovsek M; Plazas P; Savino J; Klaassen A; Boulter J; Elgoyhen AB; Katz E
Neurosci Lett; 2008 Mar; 434(2):165-9. PubMed ID: 18321647
[TBL] [Abstract][Full Text] [Related]
4. Two mutations linked to nocturnal frontal lobe epilepsy cause use-dependent potentiation of the nicotinic ACh response.
Figl A; Viseshakul N; Shafaee N; Forsayeth J; Cohen BN
J Physiol; 1998 Dec; 513 ( Pt 3)(Pt 3):655-70. PubMed ID: 9824708
[TBL] [Abstract][Full Text] [Related]
5. Properties of neuronal nicotinic acetylcholine receptor mutants from humans suffering from autosomal dominant nocturnal frontal lobe epilepsy.
Bertrand S; Weiland S; Berkovic SF; Steinlein OK; Bertrand D
Br J Pharmacol; 1998 Oct; 125(4):751-60. PubMed ID: 9831911
[TBL] [Abstract][Full Text] [Related]
6. Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometry.
Indurthi DC; Qudah T; Liao VW; Ahring PK; Lewis TM; Balle T; Chebib M; Absalom NL
Pharmacol Res; 2019 Jan; 139():215-227. PubMed ID: 30472464
[TBL] [Abstract][Full Text] [Related]
7. Distinctive effects of nicotinic receptor intracellular-loop mutations associated with nocturnal frontal lobe epilepsy.
Weltzin MM; Lindstrom JM; Lukas RJ; Whiteaker P
Neuropharmacology; 2016 Mar; 102():158-73. PubMed ID: 26561946
[TBL] [Abstract][Full Text] [Related]
8. Human nocturnal frontal lobe epilepsy: pharmocogenomic profiles of pathogenic nicotinic acetylcholine receptor beta-subunit mutations outside the ion channel pore.
Hoda JC; Gu W; Friedli M; Phillips HA; Bertrand S; Antonarakis SE; Goudie D; Roberts R; Scheffer IE; Marini C; Patel J; Berkovic SF; Mulley JC; Steinlein OK; Bertrand D
Mol Pharmacol; 2008 Aug; 74(2):379-91. PubMed ID: 18456869
[TBL] [Abstract][Full Text] [Related]
9. Mutation Linked to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy Reduces Low-Sensitivity α4β2, and Increases α5α4β2, Nicotinic Receptor Surface Expression.
Nichols WA; Henderson BJ; Marotta CB; Yu CY; Richards C; Dougherty DA; Lester HA; Cohen BN
PLoS One; 2016; 11(6):e0158032. PubMed ID: 27336596
[TBL] [Abstract][Full Text] [Related]
10. Ca2+ permeability of the (alpha4)3(beta2)2 stoichiometry greatly exceeds that of (alpha4)2(beta2)3 human acetylcholine receptors.
Tapia L; Kuryatov A; Lindstrom J
Mol Pharmacol; 2007 Mar; 71(3):769-76. PubMed ID: 17132685
[TBL] [Abstract][Full Text] [Related]
11. Pleiotropic functional effects of the first epilepsy-associated mutation in the human CHRNA2 gene.
Hoda JC; Wanischeck M; Bertrand D; Steinlein OK
FEBS Lett; 2009 May; 583(10):1599-604. PubMed ID: 19383498
[TBL] [Abstract][Full Text] [Related]
12. alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine.
Moroni M; Zwart R; Sher E; Cassels BK; Bermudez I
Mol Pharmacol; 2006 Aug; 70(2):755-68. PubMed ID: 16720757
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a fourth locus for autosomal dominant nocturnal frontal lobe epilepsy.
Combi R; Dalprà L; Malcovati M; Oldani A; Tenchini ML; Ferini-Strambi L
Brain Res Bull; 2004 Jun; 63(5):353-9. PubMed ID: 15245761
[TBL] [Abstract][Full Text] [Related]
14. Genetic basis of autosomal dominant nocturnal frontal lobe epilepsy.
Rózycka A; Trzeciak WH
J Appl Genet; 2003; 44(2):197-207. PubMed ID: 12773798
[TBL] [Abstract][Full Text] [Related]
15. Animal models for autosomal dominant frontal lobe epilepsy: on the origin of seizures.
Steinlein OK
Expert Rev Neurother; 2010 Dec; 10(12):1859-67. PubMed ID: 21091316
[TBL] [Abstract][Full Text] [Related]
16. Reduced striatal D1 receptor binding in autosomal dominant nocturnal frontal lobe epilepsy.
Fedi M; Berkovic SF; Scheffer IE; O'Keefe G; Marini C; Mulligan R; Gong S; Tochon-Danguy H; Reutens DC
Neurology; 2008 Sep; 71(11):795-8. PubMed ID: 18685138
[TBL] [Abstract][Full Text] [Related]
17. Effect of carbamazepine and oxcarbazepine on wild-type and mutant neuronal nicotinic acetylcholine receptors linked to nocturnal frontal lobe epilepsy.
Di Resta C; Ambrosi P; Curia G; Becchetti A
Eur J Pharmacol; 2010 Sep; 643(1):13-20. PubMed ID: 20561518
[TBL] [Abstract][Full Text] [Related]
18. Seizures and enhanced cortical GABAergic inhibition in two mouse models of human autosomal dominant nocturnal frontal lobe epilepsy.
Klaassen A; Glykys J; Maguire J; Labarca C; Mody I; Boulter J
Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19152-7. PubMed ID: 17146052
[TBL] [Abstract][Full Text] [Related]
19. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy.
Steinlein OK; Mulley JC; Propping P; Wallace RH; Phillips HA; Sutherland GR; Scheffer IE; Berkovic SF
Nat Genet; 1995 Oct; 11(2):201-3. PubMed ID: 7550350
[TBL] [Abstract][Full Text] [Related]
20. 5-I A-85380 and TC-2559 differentially activate heterologously expressed alpha4beta2 nicotinic receptors.
Zwart R; Broad LM; Xi Q; Lee M; Moroni M; Bermudez I; Sher E
Eur J Pharmacol; 2006 Jun; 539(1-2):10-7. PubMed ID: 16674940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
